Auditor Announces "Going Concern" For IVAX Diagnostics (IVD)
April 04, 2011 4:08 PM
IVAX Diagnostics (NYSE: IVD) announced today that its audited consolidated financial statements for the fiscal year ended December 31, 2010, included in its Annual Report on Form 10-K which was filed with the Securities and Exchange Commission on March 30, 2011, contained a report from its independent registered public accounting firm that indicates there is a substantial doubt about IVAX Diagnostics' ability to continue as a going concern.
This announcement is required by NYSE Amex Company Guide Section 610(b), which requires separate disclosure of receipt of an audit opinion containing a going concern qualification. This announcement does not represent any change or amendment to IVAX Diagnostics' consolidated financial statements or to its Annual Report on Form 10-K for the year ended December 31, 2010.
